Navigation Links
Mach One Corporation Signs Definitive Agreement to Acquire Ceres Organic Harvest, Inc.
Date:2/4/2009

BELGIUM, Wis., Feb. 4 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), Mach One Corporation, a global health company that develops biotechnology based solutions that produce positive, long term benefit to the agricultural and consumer markets, announced today that it has signed a definitive agreement to acquire Ceres Organic Harvest, Inc. an organic grain and grain-based company that supplies ingredients to the food, feed and dairy industries.

Under the terms of the agreement, Mach One will acquire 100% of the stock of Ceres for $8 million in a combination of stock and convertible debentures. 50% of the purchase price will be paid in common stock of Mach One with a valuation set at 50 cents per share with the remaining 50% of the purchase price taken by Ceres shareholders in the form of preferred convertible securities with a conversion price of 50 cents per share.

The purchase price will be funded out of available authorized shares and the transaction is not subject to financing conditions. The Company presently anticipates that the closing will occur in late February 2009.

Monte Tobin, CEO of Mach One Corporation commented, "This combination of resources and personnel between Mach One and Ceres Organic Harvest, Inc. will position us to capitalize on the work Ceres has done over the years in delivering high quality animal feed products. We in turn are excited to bring to Ceres the part of our technology that pertains to supplements and additives with the goal of delivering tremendous advancement in animal nutrition."

About Ceres Organic Harvest, Inc.

Ceres Organic Harvest, Inc. and its subsidiary Organic Grain and Milling, Inc. supply organic grain and grain-based ingredients to the food, feed and dairy industries, including varieties of wheat, flour, oats, corn, flax, barley and other products. Ceres is currently launching a number of oat-based products using a proprietary oat cultivar with substantially higher fiber and beta-glucan content. Ceres/OGM operates a grain elevator in North Dakota, with corporate offices in St. Paul, Minnesota. More info: http://www.ceresorganic.com.

About Mach One Corporation:

Mach One Corporation (www.machonecorp.com) is a global health company that provides biotechnology based solutions to help address one of the world's most pressing and costly needs--positive, long-term health and longevity benefits for disease-threatened animals of large commercial operations. Mach One provides colostrum replacement, broad spectrum immunoglobulin and Nutraceutical products that offer a new level of cost effectiveness, improved health and ease of treatment--with an initial focus on the dairy industry. Mach One intends to fully leverage the potential of its breakthrough hyper-immunity technologies--breakthroughs that one day will also include consumer applications.

Cautionary Statement: This news release may include certain "Forward-looking statements" within the meaning of Section 21E of the United States Securities Exchange Act, as amended. All statements, other than statements of historical fact, included in this release are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. This notice expressly qualifies all forward-looking statements in this release.


'/>"/>
SOURCE Mach One Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... OR (PRWEB) , ... January 18, 2017 , ... ... that provide essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 ... Cyclone V E FPGA into a compact business-card sized form factor suitable for ...
(Date:1/18/2017)... Jan. 18, 2017 Applied BioMath ( ... to drug research and development, today announced that ... and CEO of Applied BioMath, will present at ... Modeling (BAGIM) Meeting on Thursday January 19, 2017 ... , MA.   Dr. Burke,s talk "Quantitative Modeling ...
(Date:1/18/2017)... ... January 18, 2017 , ... Total ... successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, January 11, ... The procedure was an anterior cervical discectomy and fusion on a 42 year ...
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, ... that it has submitted a 510(k) to the FDA, requesting clearance of the ... functional electrical stimulation (FES) technology. , The submission marks a major milestone ...
Breaking Biology Technology:
(Date:12/20/2016)... LONDON , Dec. 20, 2016 ... car sharing, rental and leasing is stoking significant ... of radio frequency technology, Bluetooth low energy (BLE), ... emerge as the next wave of wireless technologies ... vehicle access system to advanced access systems opens ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
Breaking Biology News(10 mins):